Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Roohi, Azam ^a,b   Tabrizi, Mina ^c   Abbasi, Farzaneh ^b   Ataie Jafari, Asal ^b   Nikbin, Behrouz ^c   Larijani, Bagher ^b   Qorbani, Mostafa ^d,e   Meysamie, Alipasha ^c   Asgarian Omran, Hossein ^f   Nikmanesh, Bahram ^a   Bajouri, Arezou ^b   Shafiey, Novin ^b   Maleki, Akram ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 17; INTERLEUKIN 23; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; TH17 CELL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CHILD; NORMAL HUMAN; PATHOLOGY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; MALE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84903641452     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/718946     Document Type: Article

References (46)

1. DIAMOND Project Group, Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine 2006 23 8 857 866 2-s2.0-33746548378 10.1111/j.1464-5491.2006.01925.x (Pubitemid 44141074)
2. Alberti K. G., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 7 539 553 (Pubitemid 28319935)
3. Rowe P. A., Campbell-Thompson M. L., Schatz D. A., Atkinson M. A., The pancreas in human type 1 diabetes. Seminars in Immunopathology 2011 33 1 29 43 2-s2.0-79251634951 10.1007/s00281-010-0208-x
4. Willcox A., Richardson S. J., Bone A. J., Foulis A. K., Morgan N. G., Analysis of islet inflammation in human type 1 diabetes. Clinical and Experimental Immunology 2009 155 2 173 181 2-s2.0-58149299735 10.1111/j.1365-2249.2008.03860.x
5. Lechleitner M., Koch T., Herold M., Dzien A., Hoppichler F., Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. Journal of Internal Medicine 2000 248 1 67 76 2-s2.0-0033941219 10.1046/j.1365-2796. 2000.00705.x (Pubitemid 30470006)
6. Chase H. P., Cooper S., Osberg I., Stene L. C., Barriga K., Norris J., Eisenbarth G. S., Rewers M., Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes 2004 53 10 2569 2573 2-s2.0-4644312912 10.2337/diabetes.53.10.2569 (Pubitemid 39299263)
7. Dogan Y., Akarsu S., Ustundag B., Yilmaz E., Gurgoze M. K., Serum IL-1 β IL-2, and IL-6 in insulin-dependent diabetic children. Mediators of Inflammation 2006 2006 6 2-s2.0-33645222743 10.1155/MI/2006/59206 59206
8. Fève B., Bastard J. P., The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nature Reviews Endocrinology 2009 5 6 305 311 10.1038/nrendo.2009.62
9. Rouvier E., Luciani M.-F., Mattei M.-G., Denizot F., Golstein P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene. Journal of Immunology 1993 150 12 5445 5456 2-s2.0-0027215897 (Pubitemid 23180658)
10. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology 2005 6 11 1123 1132 2-s2.0-27544490377 10.1038/ni1254 (Pubitemid 41541790)
11. Maddur M. S., Miossec P., Kaveri S. V., Bayry J., Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. The American Journal of Pathology 2012 181 1 8 18 2-s2.0-84862695017 10.1016/j.ajpath.2012.03.044
12. Marwaha A. K., Crome S. Q., Panagiotopoulos C., Berg K. B., Qin H., Ouyang Q., Xu L., Priatel J. J., Levings M. K., Tan R., Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes. Journal of Immunology 2010 185 7 3814 3818 2-s2.0-77958136352 10.4049/jimmunol.1001860
13. Emamaullee J. A., Davis J., Merani S., Toso C., Elliott J. F., Thiesen A., Shapiro A. M. J., Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009 58 6 1302 1311 2-s2.0-66649113381 10.2337/db08-1113
14. Derynck R., Miyazono K., Derynck R., Miyazono K., TGF-beta and the TGF-beta family. The TGF-Beta Family 2008 Cold Spring Harbor, NY, USA Cold Spring Harbor Laboratory Press 29 43
15. Prud'homme G. J., Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations. Laboratory Investigation 2007 87 11 1077 1091 2-s2.0-35348940144 10.1038/labinvest.3700669 (Pubitemid 47610581)
16. Li M. O., Wan Y. Y., Sanjabi S., Robertson A.-K. L., Flavell R. A., Transforming growth factor- β regulation of immune responses. Annual Review of Immunology 2006 24 99 146 2-s2.0-33646164362 10.1146/annurev.immunol.24. 021605.090737
17. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L., Kuchroo V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 7090 235 238 2-s2.0-33646577466 10.1038/nature04753
18. Veldhoen M., Hocking R. J., Atkins C. J., Locksley R. M., Stockinger B., TGF β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006 24 2 179 189 2-s2.0-32244442562 10.1016/j.immuni.2006.01.001 (Pubitemid 43214587)
19. Mangan P. R., Harrington L. E., O'Quinn D. B., Helms W. S., Bullard D. C., Elson C. O., Hatton R. D., Wahl S. M., Schoeb T. R., Weaver C. T., Transforming growth factor- β induces development of the T H17 lineage. Nature 2006 441 7090 231 234 2-s2.0-33646560950 10.1038/nature04754
20. Das J., Ren G., Zhang L., Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. The Journal of Experimental Medicine 2009 206 11 2407 2416 10.1084/jem.20082286
21. Boniface K., Blom B., Liu Y.-J., de Waal Malefyt R., From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunological Reviews 2008 226 1 132 146 2-s2.0-55149087226 10.1111/j.1600-065X. 2008.00714.x
22. Olivieri A., de Angelis S., Dionisi S., D'Annunzio G., Locatelli M., Marinaro M., Bonato V., Amendola A., Songini M., Velluzzi F., Schirru C., Cotichini R., Stazi M. A., Dotta F., Lorini R., Bottazzo G. F., Boirivant M., Serum transforming growth factor β 1 during diabetes development in non-obese diabetic mice and humans. Clinical and Experimental Immunology 2010 162 3 407 414 2-s2.0-79952477064 10.1111/j.1365-2249.2010.04253.x
23. Zhi W., Sharma A., Purohit S., Miller E., Bode B., Anderson S. W., Reed J. C., Steed R. D., Steed L., Hopkins D., She J.-X., Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Molecular & Cellular Proteomics 2011 10 11 M111.012203 2-s2.0-84879792266
24. Han D., Leyva C. A., Matheson D., Mineo D., Messinger S., Blomberg B. B., Hernandez A., Meneghini L. F., Allende G., Skyler J. S., Alejandro R., Pugliese A., Kenyon N. S., Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes. Clinical Immunology 2011 139 3 290 301 2-s2.0-79955965390 10.1016/j.clim.2011.02.016
25. Azar S. T., Salti I., Zantout M. S., Major S., Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism 2000 85 12 4680 4682 2-s2.0-0034485840 10.1210/jc.85.12.4680 (Pubitemid 32157651)
26. Abbasi F., Amiri P., Sayahpour F. A., Pirmoradi S., Abolhalaj M., Larijani B., Bazzaz J. T., Amoli M. M., TGF- β and IL-23 gene expression in unstimulated PBMCs of patients with diabetes. Endocrine 2012 41 3 430 434 2-s2.0-84862686498 10.1007/s12020-011-9578-7
27. Tesch G. H., Role of macrophages in complications of Type 2 diabetes. Clinical and Experimental Pharmacology and Physiology 2007 34 10 1016 1019 2-s2.0-34547967661 10.1111/j.1440-1681.2007.04729.x (Pubitemid 47274561)
28. +/PKC/MAPKs and PI3K/Akt/mTOR signal pathways. Journal of Cellular Physiology 2010 224 1 59 70 2-s2.0-77952515152 10.1002/jcp.22091
29. Isono M., Iglesias-de la Cruz M. C., Chen S., Hong S. W., Ziyadeh F. N., Extracellular signal-regulated kinase mediates stimulation of TGF- β 1 and matrix by high glucose in mesangial cells. Journal of the American Society of Nephrology 2000 11 12 2222 2230 2-s2.0-0033662740
30. Wan Y. Y., Flavell R. A., The roles for cytokines in the generation and maintenance of regulatory T cells. Immunological Reviews 2006 212 114 130 2-s2.0-33746348281 10.1111/j.0105-2896.2006.00407.x (Pubitemid 44116704)
31. You S., Thieblemont N., Alyanakian M.-A., Bach J.-F., Chatenoud L., Transforming growth factor- β and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunological Reviews 2006 212 185 202 2-s2.0-33746330703 10.1111/j.0105-2896.2006.00410.x (Pubitemid 44116709)
32. Franceschi C., Bonafè M., Valensin S., Olivieri F., de Luca M., Ottaviani E., De Benedictis G., Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 2000 908 244 254 2-s2.0-0033911488 (Pubitemid 30462008)
33. Singh T., Newman A. B., Inflammatory markers in population studies of aging. Ageing Research Reviews 2011 10 3 319 329 2-s2.0-79955973916 10.1016/j.arr.2010.11.002
34. McFarlane D., Wolf R. F., McDaniel K. A., White G. L., Age-associated alteration in innate immune response in captive baboons. Journals of Gerontology A: Biological Sciences and Medical Sciences 2011 66 12 1309 1317 2-s2.0-81055133492 10.1093/gerona/glr146
35. Willis E. L., Wolf R. F., White G. L., McFarlane D., Age- and gender-associated changes in the concentrations of serum TGF-1 β DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis). General and Comparative Endocrinology 2014 195 21 27 10.1016/j.ygcen.2013.10.004
36. Lin Y., Nakachi K., Ito Y., Kikuchi S., Tamakoshi A., Yagyu K., Watanabe Y., Inaba Y., Variations in serum transforming growth factor- β 1 levels with gender, age and lifestyle factors of healthy Japanese adults. Disease Markers 2009 27 1 23 28 2-s2.0-70350495647 10.3233/DMA-2009-0643
37. Okamoto Y., Gotoh Y., Uemura O., Tanaka S., Ando T., Nishida M., Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; Population study of serum TGF-beta 1 level in Japanese. Disease Markers 2005 21 2 71 74 2-s2.0-21044449607 (Pubitemid 40875150)
38. Grainger D. J., Mosedale D. E., Metcalfe J. C., TGF- β in blood: a complex problem. Cytokine and Growth Factor Reviews 2000 11 1-2 133 145 2-s2.0-0034022167 10.1016/S1359-6101(99)00037-4 (Pubitemid 30169734)
39. Saurwein-Teissl M., Blasko I., Zisterer K., Neuman B., Lang B., Grubeck-Loebenstein B., An imbalance between pro- and anti-inflammatory cytokines, a characteristic feature of old age. Cytokine 2000 12 7 1160 1161 2-s2.0-0033926255 10.1006/cyto.2000.0679 (Pubitemid 30479506)
40. Bending D., de la Peña H., Veldhoen M., Phillips J. M., Uyttenhove C., Stockinger B., Cooke A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. Journal of Clinical Investigation 2009 119 3 565 572 2-s2.0-67650650890 10.1172/JCI37865
41. Martin-Orozco N., Chung Y., Chang S. H., Wang Y.-H., Dong C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. European Journal of Immunology 2009 39 1 216 224 2-s2.0-60549086638 10.1002/eji.200838475
42. Shao S., He F., Yang Y., Yuan G., Zhang M., Yu X., Th17 cells in type 1 diabetes. Cellular Immunology 2012 280 1 16 21 2-s2.0-84871018881 10.1016/j.cellimm.2012.11.001
43. Langrish C. L., Chen Y., Blumenschein W. M., Mattson J., Basham B., Sedgwick J. D., McClanahan T., Kastelein R. A., Cua D. J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 2005 201 2 233 240 2-s2.0-13244283212 10.1084/jem.20041257 (Pubitemid 40189432)
44. Mus A. M. C., Cornelissen F., Asmawidjaja P. S., Van Hamburg J. P., Boon L., Hendriks R. W., Lubberts E., Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of Interleukin-22, but not Interleukin-21, in autoimmune experimental arthritis. Arthritis and Rheumatism 2010 62 4 1043 1050 2-s2.0-77950548359 10.1002/art.27336
45. Mensah-Brown E. P. K., Shahin A., Al-Shamsi M., Lukic M. L., New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes. Annals of the New York Academy of Sciences 2006 1079 157 160 2-s2.0-33845712953 10.1196/annals.1375.024 (Pubitemid 44968717)
46. Goldberg I. J., Clinical review 124: diabetic dyslipidemia-causes and consequences. Journal of Clinical Endocrinology and Metabolism 2001 86 3 965 971 2-s2.0-0035053234 10.1210/jc.86.3.965 (Pubitemid 32322966)